Akebia to Host Conference Call to Provide Business Update

CAMBRIDGE, Mass.


,


July 26, 2022


/PRNewswire/ —

Akebia Therapeutics, Inc.

(Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results for the second quarter ended

June 30, 2022

on

Thursday, August 4, 2022

following the close of financial markets.

Akebia will host a conference call on

Thursday, August 4

at

4:30 p.m. ET

to discuss its financial results and provide a general business update. To listen to the conference call on

August 4


^th

, please dial (833) 630-1955 (domestic) or (412) 317-1836 (international) and ask to join into the Akebia Therapeutics call. The call will also be webcast LIVE and can be accessed via the Investors section of Akebia’s website at

http://ir.akebia.com

.

A replay of the conference call will be available two hours after the completion of the call through

August 10, 2022

. To access the replay, dial (877) 344-7529 (domestic) or (412) 317-0088 (international) and reference replay access code 3608580. An online archive of the conference call can be accessed via the Investors section of Akebia’s website at

http://ir.akebia.com

.

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in

Cambridge, Massachusetts

. For more information, please visit our website at

www.akebia.com

, which does not form a part of this release.

Akebia Therapeutics Contact



Mercedes Carrasco



[email protected]

View original content to download multimedia:

https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-second-quarter-financial-results-301592484.html

SOURCE Akebia Therapeutics